Safer Shrimp Imports Act
Key claim: HR3324 would prohibit shrimp imports from countries lacking FDA-equivalent food inspection systems or inspection agreements, deeming non-compliant shrimp adulterated and barring it from interstate commerce.
Abstract
(HR3324 · 119th Congress) Safer Shrimp Imports Act This bill prohibits the importation of shrimp from countries that do not have food inspection systems equivalent to the Food and Drug Administration (FDA) inspection system for shrimp, or that have not entered into an agreement with the FDA facilitating U.S. inspection of their food facilities. Specifically, the FDA must seek to enter into arrangements and agreements with the government of each country with at least one facility that manufactures, processes, packs, or holds shrimp for consumption in the United States to facilitate FDA inspection of such facilities. The bill prohibits the importation of shrimp that is manufactured, processed, packed, or held in a country (1) that has not entered into an inspection arrangement or agreement with the FDA, or (2) the food inspection system of which is not equivalent to the FDA’s food inspection system with respect to shrimp. To be considered equivalent, a country’s food inspection system must include staffing that ensures uniform enforcement of applicable laws and regulations, and must provide for the enforcement of laws and regulations that address conditions under which shrimp are raised and transported to processing facilities. Further, shrimp imported or offered for import into the United States that have been manufactured, processed, packed, or held in a country that is not compliant with these requirements are deemed adulterated, and thus may not be introduced into interstate commerce. Latest action (2025-05-13): Referred to the House Committee on Energy and Commerce.
Why this matters
The Safer Shrimp Imports Act introduces a commodity-specific import equivalency regime, using the FD&C Act’s adulteration designation as the enforcement lever rather than tariffs or AD/CVD duties. If enacted, it would establish a template for extending FDA foreign-inspection equivalency (already used for seafood generally under HACCP) into a binding market-access precondition, with meaningful implications for import volumes, domestic shrimp prices, and trade relationships with major shrimp-exporting nations.